Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Evolus Inc (EOLS)

Evolus Inc (EOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Shares of Evolus Are Jumping Thursday Motley Fool - Thu Jul 27, 2023

The stock climbed on record second-quarter revenue and a raise in full-year guidance.

EOLS : 11.46 (-0.35%)
Twitter Faces Threats From AI and Threads Motley Fool - Sat Jul 15, 2023

AI is changing the open internet landscape, and Meta's new Threads app is looking to take a bite out of Twitter's audience.

META : 441.38 (-10.56%)
GOOGL : 156.00 (-1.97%)
ADBE : 473.44 (-0.77%)
GOOG : 157.95 (-1.96%)
EOLS : 11.46 (-0.35%)
DIS : 112.77 (-1.01%)
PM : 96.09 (-2.96%)
MODG : 15.72 (-2.84%)
GOLF : 61.57 (-2.52%)
TWTR : 53.70 (+0.66%)
WMT : 60.21 (+0.57%)
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 9, 2023

Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -30.77% and 1.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

EOLS : 11.46 (-0.35%)
AYRWF : 2.3100 (-7.23%)
Evolus to Report First Quarter 2023 Results and Provide Business Update Business Wire - Fri May 5, 2023

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that it will report its first quarter 2023 financial...

EOLS : 11.46 (-0.35%)
Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates Zacks - Thu May 4, 2023

Bio-Rad (BIO) delivered earnings and revenue surprises of 3.09% and 0.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BIO : 275.60 (-0.94%)
EOLS : 11.46 (-0.35%)
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates Zacks - Tue Apr 11, 2023

OrganiGram (OGI) delivered earnings and revenue surprises of -100% and 9.74%, respectively, for the quarter ended February 2023. Do the numbers hold clues to what lies ahead for the stock?

OGI : 1.8600 (-3.63%)
EOLS : 11.46 (-0.35%)
Evolus, Inc. (EOLS) Reports Q4 Loss, Tops Revenue Estimates Zacks - Wed Mar 8, 2023

Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -14.29% and 0.39%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

EOLS : 11.46 (-0.35%)
MGNX : 14.37 (-8.47%)
Evolus Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update Business Wire - Wed Mar 8, 2023

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today reported financial results for the fourth quarter and full...

EOLS : 11.46 (-0.35%)
TG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates Zacks - Tue Feb 28, 2023

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -50% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TGTX : 13.91 (-0.50%)
EOLS : 11.46 (-0.35%)
Evolus to Participate in the Barclays Global Healthcare Conference Business Wire - Tue Feb 28, 2023

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of its management team will be participating...

EOLS : 11.46 (-0.35%)

Barchart Exclusives

Guess vs. Levi Strauss: Which Breakout Dividend Stock Is a Better Buy? Barchart - 1 hour ago
With Levi Strauss and Guess stock prices surging and both apparel giants impressing shareholders with their dividend payments, which of the two is a better buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot